Found 0 matching trials
A Phase II Clinical Trial on Neo-adjuvant Pembrolizumab in Patients With pT3b-T4a/b cN0M0 Melanoma.
PHASE2This study, called NeoSenti, is exploring whether giving one dose of the im...
The MAR Method Versus the Visual Estimation Method in Predicting External Blood Loss
NAThe goal of this educational clinical trial is to determine whether the MAR...
Location
Baskent University
Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Risk Heart Failure Patients
NAPatients with heart failure (HF) represent a large population of patients w...
Status
Active Not Recruiting
Location
University of Rochester Medical Center
Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer
EARLY_PHASE1This pilot trial studies how well chemokine modulation therapy works when g...
Location
Roswell Park Cancer Institute
Gene Therapy for Neurofibromatosis Type 2 (NF2) with ST002
NAThis is an open-label, single-arm, dose-escalation pilot study to evaluate ...
Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity
PHASE2For patients with malignant pleural mesothelioma that has grown despite tre...
Location
Dana Farber Cancer Institute
Atrial Anomalies Predict Silent Atrial Fibrillation Detected by Implantable Cardiac Monitor in Cryptogenic Stroke
NACryptogenic stroke (CS) causes about 30% of admissions to a stroke unit. Si...
A Trial of Bardoxolone Methyl in Patients With CKD at Risk of Rapid Progression (MERLIN)
PHASE2This multi-center, randomized, double-blind, placebo-controlled, Phase 2 tr...
Location
California Institute of Renal Research